中国药物警戒
中國藥物警戒
중국약물경계
CHINESE JOURNAL OF PHARMACOVIGILANCE
2014年
7期
429-431,438
,共4页
硫酸镁注射液%胎儿%骨骼异常%风险管理
硫痠鎂註射液%胎兒%骨骼異常%風險管理
류산미주사액%태인%골격이상%풍험관리
magnesium sulfate injection%fetus%skeletal abnormalities%risk management
根据国内外对硫酸镁注射液风险控制措施的情况，进一步分析其安全警告的背景和依据，探讨硫酸镁注射液和胎儿骨骼异常之间的关联性。同时硫酸镁注射液新暴露的风险，导致风险/效益平衡的变化，需要引起各方的重视并采取相应措施。
根據國內外對硫痠鎂註射液風險控製措施的情況，進一步分析其安全警告的揹景和依據，探討硫痠鎂註射液和胎兒骨骼異常之間的關聯性。同時硫痠鎂註射液新暴露的風險，導緻風險/效益平衡的變化，需要引起各方的重視併採取相應措施。
근거국내외대류산미주사액풍험공제조시적정황，진일보분석기안전경고적배경화의거，탐토류산미주사액화태인골격이상지간적관련성。동시류산미주사액신폭로적풍험，도치풍험/효익평형적변화，수요인기각방적중시병채취상응조시。
According to the situation of magnesium sulfate injection risk control measures at home and abroad, the background and basis of its safety warnings are further analyzed so as to explore the correlation between magnesium sulfate injection and fetal skeletal abnormalities. The newly exposed risk and the magnesium sulfate injection, which leads to change the balance of risk/benefit, need each side to give more attention and take corresponding measures.
